Skip to main content
TOWA PHARMACEUTICAL CO.,LTD. logo

TOWA PHARMACEUTICAL CO.,LTD. — Investor Relations & Filings

Ticker · 4553 ISIN · JP3623150004 LEI · 35380036BH1C3PNO2426 T Manufacturing
Open in API
Filings indexed 69 across all filing types
Latest filing 2020-08-14 Interim / Quarterly Rep…
Country JP Japan
Listing T 4553

About TOWA PHARMACEUTICAL CO.,LTD.

https://www.towayakuhin.co.jp/english/

TOWA PHARMACEUTICAL CO.,LTD. is a pharmaceutical company specializing in the research, development, manufacturing, and marketing of generic drugs. Founded in 1951, the company is dedicated to providing high-quality and high added-value therapeutic solutions. Its product portfolio primarily consists of generic medications, which are distributed as ethical drugs, and also includes other products such as vitamins and antibiotics. The company focuses on the entire lifecycle of its pharmaceutical products, from initial development to final distribution, to meet various healthcare needs.

Recent filings

Filing Released Lang Actions
四半期報告書－第65期第1四半期(令和2年4月1日－令和2年6月30日)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for Towa Pharmaceutical Co., Ltd., covering the first quarter of the 65th fiscal year (April 1, 2020, to June 30, 2020). It contains detailed financial statements, including the consolidated balance sheet, income statement, and comprehensive income statement, as well as notes to the financial statements. This meets the criteria for an Interim/Quarterly Report (IR) as it provides substantive financial data and analysis for a period shorter than a full fiscal year. Q1 2021
2020-08-14 Japanese
有価証券報告書－第64期(平成31年4月1日－令和2年3月31日)
Annual Report Classification · 100% confidence The document is identified as a '有価証券報告書' (Yuuka Shouken Houkokusho), which is the Japanese equivalent of an Annual Report (10-K). The text explicitly states the filing type, the fiscal year (第64期, 2019-04-01 to 2020-03-31), and includes XBRL tags typical of a comprehensive annual financial filing. It is not an announcement, but the full report itself. FY 2020
2020-06-25 Japanese
四半期報告書－第64期第3四半期(令和1年10月1日－令和1年12月31日)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for Towa Pharmaceutical Co., Ltd., covering the third quarter of the 64th fiscal year (period ending December 31, 2019). It contains detailed financial statements, including the balance sheet, income statement, and comprehensive income statement, as well as notes to the financial statements. This fits the definition of an Interim/Quarterly Report (IR) as it provides comprehensive financial data for a period shorter than a full fiscal year. 9M 2020
2020-02-13 Japanese
四半期報告書－第64期第2四半期(2019/07/01－2019/09/30)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for Towa Pharmaceutical Co., Ltd. for the second quarter of the 64th fiscal period (ending September 30, 2019). It contains detailed financial statements, including the balance sheet, income statement, and cash flow analysis, as required by the Financial Instruments and Exchange Act of Japan. It is not an announcement or a summary, but the full report itself. Q2 2020
2019-11-12 Japanese
訂正四半期報告書－第64期第1四半期(2019/04/01－2019/06/30)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for Towa Pharmaceutical Co., Ltd. for the first quarter of the 64th fiscal year (April 1, 2019 to June 30, 2019). It contains detailed financial statements, including the balance sheet, income statement, and notes to the financial statements, as well as management's analysis of the financial condition. Although the title mentions 'Correction' (訂正), it is a full financial report containing substantive data, not just an announcement or certification. Therefore, it is classified as an Interim/Quarterly Report. Q1 2020
2019-10-31 Japanese
訂正有価証券報告書－第63期(平成30年4月1日－平成31年3月31日)
Annual Report Classification · 100% confidence The document is a '訂正有価証券報告書' (Amended Securities Report) filed with the Kinki Finance Bureau in Japan. It contains detailed financial data, including consolidated management indicators, balance sheets, and cash flow statements for the fiscal year ending March 31, 2019. In the context of Japanese financial reporting, an '有価証券報告書' (Yuuka Shouken Houkokusho) is the equivalent of an Annual Report (10-K). Although it is an amendment, it contains the full financial disclosure required for the annual period. FY 2019
2019-10-31 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.